Stem Cell Therapy: Promising Treatment in Heart Failure?
- 25 January 2013
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 10 (1) , 73-80
Abstract
Cardiac repair through the use of regenerative medicine has been a considerable research focus over the last decade. Several stem cell types have been investigated over this timeframe as potential candidates to target post-infarction heart failure. The progression of investigation through the rigors of clinical trial design has provided some answers as to the potential clinical utility of this therapy; although there are many questions that remain. This review will concentrate on the clinical trial results of stem cell therapy for cardiac repair since the turn of the century and discuss some of the points that need clarification before this form of therapy can be considered for widespread applicability.Keywords
This publication has 65 references indexed in Scilit:
- Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial InfarctionJAMA, 2012
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart FailureJAMA, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular FunctionJAMA, 2011
- RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialThe Lancet, 2011
- Challenges in the Translation of Cardiovascular Cell TherapyJournal of Nuclear Medicine, 2010
- Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell DeliveryJACC, 2009
- Evidence for Cardiomyocyte Renewal in HumansScience, 2009
- Cost of Hospital Care for Older Adults with Heart Failure: Medical, Pharmaceutical, and Nursing CostsHealth Services Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006